Brunaud C, Carosella E D, Charpentier B
Laboratoire d'Immunologie cellulaire, Pasteur Mérieux Sérums et Vaccins, Marcy L'Etoile, France.
Cell Immunol. 1992 Oct 1;144(1):105-16. doi: 10.1016/0008-8749(92)90229-i.
In the present work, we tested in SCID and Balb/c mice the activity of T hybridoma transfected with T cell receptor (TCR) alpha/beta chain genes. A T cell hybridoma denoted D011107 was used as recipient for transfection of cytotoxic KB5C20 TCR alpha/beta heterodimer genes by protoplast fusion or electroporation. After transfection, the parental D011107 T cell line reexpressed CD5 and CD4 surface molecules. In vitro, we noted strong proliferation and unusual cytotoxic reactivities against H-2k target cells although the transfected cell line does not express the CD8 molecule. The fate of parental and transfected cells was examined in severe combined immunodeficient (SCID) and Balb/c mice at Day 16 after intravenous injection. Cells from bone marrow, thymus, and spleen tissues were analyzed by immunofluorescence. The transfected T cell hybridoma was CD3+ Desire 1+ CD4+ Thy1.2. The SCID mice grafted with the transfected T cell hybridoma presented a high percentage of CD3+ (15%), CD4+ (27%), Thy1.2+ (27.52%), and Desire 1+ (8.74%) cells in the spleen. The percentages of CD3+ (6.2%) and Thy1.2+ (5.06%) cells in the spleen from SCID mice grafted with parental T cell D011107 and from untreated SCID were similar and lower (CD3+, 3.52%; Thy1.2+, 4.34%). It seems that transfected T cells hybridoma grafted in the SCID mice induce significant expression of CD4+ Thy1.2+ Desire 1- cells (17%) in the spleen. These results indicate that transfected T cells graft may allow T cell differentiation. In Balb/c mice, the percentage of different T cell subsets in bone marrow, thymus, or spleen cells in mice injected with transfected T cells was similar to that in untreated mice. We did not observe any cytotoxic or significant allogeneic proliferation in vitro.
在本研究中,我们在严重联合免疫缺陷(SCID)小鼠和Balb/c小鼠中测试了转染了T细胞受体(TCR)α/β链基因的T杂交瘤的活性。一个名为D011107的T细胞杂交瘤被用作受体,通过原生质体融合或电穿孔转染细胞毒性KB5C20 TCRα/β异二聚体基因。转染后,亲代D011107 T细胞系重新表达CD5和CD4表面分子。在体外,我们注意到转染后的细胞系虽然不表达CD8分子,但对H-2k靶细胞具有强烈的增殖和异常的细胞毒性反应。在静脉注射后第16天,在严重联合免疫缺陷(SCID)小鼠和Balb/c小鼠中检查亲代细胞和转染细胞的命运。通过免疫荧光分析来自骨髓、胸腺和脾脏组织的细胞。转染的T细胞杂交瘤为CD3+ Desire 1+ CD4+ Thy1.2。移植了转染的T细胞杂交瘤的SCID小鼠脾脏中CD3+(15%)、CD4+(27%)、Thy1.2+(27.52%)和Desire 1+(8.74%)细胞的百分比很高。移植亲代T细胞D011107的SCID小鼠和未处理的SCID小鼠脾脏中CD3+(6.2%)和Thy1.2+(5.06%)细胞的百分比相似且较低(CD3+,3.52%;Thy1.2+,4.34%)。似乎移植到SCID小鼠中的转染T细胞杂交瘤在脾脏中诱导了CD4+ Thy1.2+ Desire 1-细胞(17%)的显著表达。这些结果表明,移植转染的T细胞可能允许T细胞分化。在Balb/c小鼠中,注射转染T细胞的小鼠骨髓、胸腺或脾脏细胞中不同T细胞亚群的百分比与未处理小鼠相似。我们在体外未观察到任何细胞毒性或显著的同种异体增殖。